Filing Details

Accession Number:
0001179110-12-000755
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-12 18:53:09
Reporting Period:
2012-01-10
Filing Date:
2012-01-12
Accepted Time:
2012-01-12 18:53:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314870 Kristen Metza Gilead Sciences, Inc.
333 Lakeside Drive
Foster City CA 94404
Svp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-01-10 11,500 $32.79 29,832 No 4 M Direct
Common Stock Disposition 2012-01-10 11,500 $44.95 18,332 No 4 S Direct
Common Stock Acquisiton 2012-01-10 6,500 $30.95 24,832 No 4 M Direct
Common Stock Disposition 2012-01-10 6,500 $44.95 18,332 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2012-01-10 6,500 $0.00 6,500 $30.95
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2012-01-10 11,500 $0.00 11,500 $32.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-07-26 No 4 M Direct
8,000 2017-01-22 No 4 M Direct
Footnotes
  1. The stock options have a five year vesting schedule. 20% of the options vested on July 26, 2007, the first anniversary of the grant. The balance vested 5% quarterly thereafter until fully vested on July 26, 2011.
  2. The stock options have a five year vesting schedule. 20% of the options vested on January 22, 2008, the first anniversary of the grant. The balance vested 5% quarterly thereafter until fully vested on January 22, 2012.